ExploreWatchlistsPricing
  1. JP-listed companies
  2. NIPPON CHEMIPHAR CO., LTD.
  3. Financials
  4. Revenue growth (%)

NIPPON CHEMIPHAR CO., LTD. (4539)

Market cap
¥7.1B
P/E ratio
40.1x
Nippon Chemiphar manufactures and sells prescription pharmaceuticals while also providing contract safety testing and healthcare services through its subsidiaries.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Mar 31, 20255.9-330.74%
Mar 31, 2024-2.6-11.68%
Mar 31, 2023-2.9-195.10%
Mar 31, 20223.1-550.00%
Mar 31, 2021-0.7-90.42%
Mar 31, 2020-7.1+118.46%
Mar 31, 2019-3.2+225.00%
Mar 31, 2018-1-516.67%
Mar 31, 20170.2-82.61%
Mar 31, 20161.4-86.35%
Mar 31, 201510.1-6418.75%
Mar 31, 2014-0.2-101.33%
Mar 31, 201312

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat